Pharma Mar SA
Elena obtained her degree in economics, with a focus on the Public Sector and Monetary Economy, from the Complutense University of Madrid and a master in Corporate Tax Consultancy from ICADE University. She started her professional career at PriceWaterhouse in Madrid in the Audit division and then moved to the Tax, Legal and Financial Division, where she worked until 1994. She was a Senior Consultant in C&G, where she managed tax consultancy and financial projects in various companies, both public and private, within the logistics, transport and technological research sectors. In 1998, she returned to PricewaterhouseCoopers Madrid as Consultant within the Tax, Legal and Financial Division to various global financial sector clients. She joined PharmaMar in 2002 as the Financial Comptroller., a position she held until she was appointed Finance Director in April 2008.
This person is not in any offices
Pharma Mar SA
Pharma Mar SA is a Spain-based company engaged in the bio therapeutic drugs manufacture. The Company focuses on research, development and marketing of bio-active principles, primarily from marine origin, for application in human diseases treatment, including antitumour, antiviral and immunomodulation, as well as tropical diseases areas. It manufactures and sells Yondelis, a synthetically modified antitumor agent, which is derived from sea squirts and is implemented in the treatment of soft tissue sarcomas and relapsed ovarian cancer. Furthermore, the Company's products pipeline comprises drug candidates and agents for cancer treatment, such as Aplidin, PM01183 and PM060184. The Company operates through subsidiaries in Italy, Germany, France, and the United States, among others.